158 related articles for article (PubMed ID: 9855064)
21. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
22. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
23. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
[TBL] [Abstract][Full Text] [Related]
24. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
Prins M; Veugelers PJ
AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
[TBL] [Abstract][Full Text] [Related]
25. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.
Pehrson P; Lindbäck S; Lidman C; Gaines H; Giesecke J
AIDS; 1997 Jul; 11(8):1007-12. PubMed ID: 9223735
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study.
Ranin J; Salemovic D; Brmbolic B; Marinkovic J; Boricic I; Pesic PI; Zerjav S; Stanojevic M; Jevtovic D
Curr HIV Res; 2018; 16(3):222-230. PubMed ID: 30014804
[TBL] [Abstract][Full Text] [Related]
27. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
28. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985.
Brettle RP; McNeil AJ; Burns S; Gore SM; Bird AG; Yap PL; MacCallum L; Leen CS; Richardson AM
AIDS; 1996 Apr; 10(4):419-30. PubMed ID: 8728047
[TBL] [Abstract][Full Text] [Related]
29. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
[TBL] [Abstract][Full Text] [Related]
30. Continued drug use and other cofactors for progression to AIDS among injecting drug users.
Ronald PJ; Robertson JR; Elton RA
AIDS; 1994 Mar; 8(3):339-43. PubMed ID: 7913328
[TBL] [Abstract][Full Text] [Related]
31. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
32. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.
Ragni MV; Belle SH
J Infect Dis; 2001 Apr; 183(7):1112-5. PubMed ID: 11237838
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
[TBL] [Abstract][Full Text] [Related]
34. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
Hsieh MH; Wang SC; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
[TBL] [Abstract][Full Text] [Related]
36. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
37. Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.
Raboud J; Anema A; Su D; Klein MB; Zakaryan A; Swan T; Palmer A; Hosein S; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Hogg RS; Cooper C;
HIV Clin Trials; 2012; 13(2):90-102. PubMed ID: 22510356
[TBL] [Abstract][Full Text] [Related]
38. The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.
Inshaw J; Leen C; Fisher M; Gilson R; Hawkins D; Collins S; Fox J; McLean K; Fidler S; Phillips A; Lattimore S; Babiker A; Porter K;
PLoS One; 2015; 10(7):e0132772. PubMed ID: 26225723
[TBL] [Abstract][Full Text] [Related]
39. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.
McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Cameron S; Dillon JF; Goldberg DJ
J Viral Hepat; 2011 Apr; 18(4):e126-33. PubMed ID: 20964793
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
